Showing results (51-60 of 110) with videos related to
Sort By:
Pageof 11
BJGP Open|August 12, 2025
Enablers and barriers to coalface primary care reform in England: a qualitative studyClaire Jackson Am, Caroline Nicholson, Jenny Job, et al.Health Research Policy and Systems|February 3, 2017
Economies of scale and scope in publicly funded biomedical and health research: evidence from the literatureKarla Hernandez-Villafuerte, Jon Sussex, Enora Robin, et al.Personalized Medicine|May 23, 2018
Can and should value-based pricing be applied to molecular diagnostics?Martina Garau, Adrian Towse, Louis Garrison, et al.Journal of Comparative Effectiveness Research|July 13, 2017
Indication-specific pricing of pharmaceuticals in the US healthcare systemSteven D Pearson, William B Dreitlein, Chris Henshall, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 10, 2024
Proposal for a General Outcome-Based Value Attribution Framework for Combination TherapiesLotte Steuten, Mickael Lothgren, Andrew Bruce, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 2, 2021
How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?Adrian Towse, Kalipso Chalkidou, Isobel Firth, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 8, 2022
Considering Severity in Health Technology Assessment: Can We Do Better?Chris Skedgel, Nadine Henderson, Adrian Towse, et al.BJGP Open|January 16, 2024
Identifying where hospital and community trusts are managing general practices in England: a service mapping studyCharlotte Davies, Catherine L Saunders, Fifi Olumogba, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 12, 2013
A pilot study of multicriteria decision analysis for valuing orphan medicinesJon Sussex, Pierrick Rollet, Martina Garau, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4]Patricia M Danzon, Michael F Drummond, Adrian Towse, et al.Pageof 11